Atlas Trials

Fosfomycin Versus Meropenem or Ceftriaxone in Bacteriemic Infections Caused by Multidrug Resistance in E.Coli

Clinical trial NCT02142751 · COMPLETED

Trial details

NCT number
NCT02142751
Sponsor
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Infection Due to ESBL Escherichia Coli
Start date
2014-07-01
Primary completion
2018-12-01
Enrollment
161

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.